Table 6.

Univariate survival analysis: progression rate in low- and high-risk groups of sCr, proteinuric, and histologic parameters in 23 patients treated with steroids and cyclophosphamidea

Risk FactorsProgressionP
sCr < versus ≥1.74 (12 versus 11)0 versus 73%<0.0001
FEIgG/SG < versus ≥0.00034 (14 versus 9)0 versus 89%<0.0001
FEIgG/SG + sCr (15 versus 8)b0 versus 100%<0.0001
FEα1m/SG < versus ≥0.04 (12 versus 11)0 versus 73%<0.0003
TID score < versus ≥3 (8 versus 15)0 versus 53%0.0210
GGS < versus ≥20% (12 versus 11)8 versus 64%0.0074
uα2m/g uCr/SG < versus ≥0.11 (15 versus 8)7 versus 87%0.0004
24hP/SG < versus ≥0.034 (9 versus 14)0 versus 57%0.0120
Cellular crescents < versus ≥17% (8 versus 15)25 versus 40%0.5960
  • a Numbers in parentheses are the number of patients of the low- and high-risk groups, respectively.

  • b Low-risk group: the two markers or only one below the cutoff; high-risk group: both markers above the cutoff.